U.S. Research Leadership at a Crossroads - The Impact of Reducing NIH Indirect-Cost Coverage

Amar H Kelkar

N Engl J Med. 2025 Jun 5;392(21):2081-2084. doi: 10.1056/NEJMp2502451. Epub 2025 May 7.
Abstract
The Trump administration�s proposed 15% cap on indirect-cost rates for National Institutes of Health grants risks upending the paradigm that underpins American leadership in medical research.